SUO 2019: Regulatory Issues and the Institutional Review Board (IRB)

SUO 2019 regulatory issues facing investigators for clinical trials, multi-institutional studies or collaborations, data use agreements in addition to IRB review, essential steps for the initiation of a clinical trial, FDA form 1572, Adverse events reporting in clinical trials, measures to prevent fraudulent reports and data fabrications.

Read the full article here

Related Articles